2024-04-012025-03-312025-03-31false07209577DR. LEATHER LIMITED2025-12-0982990falseiso4217:GBPxbrli:pure072095772024-03-31072095772025-03-31072095772024-04-012025-03-31072095772023-03-31072095772024-03-31072095772023-04-012024-03-3107209577bus:SmallEntities2024-04-012025-03-3107209577bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3107209577bus:FullAccounts2024-04-012025-03-3107209577bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107209577core:WithinOneYear2025-03-3107209577core:AfterOneYear2025-03-3107209577core:WithinOneYear2024-03-3107209577core:AfterOneYear2024-03-3107209577core:ShareCapital2025-03-3107209577core:SharePremium2025-03-3107209577core:RevaluationReserve2025-03-3107209577core:OtherReservesSubtotal2025-03-3107209577core:RetainedEarningsAccumulatedLosses2025-03-3107209577core:ShareCapital2024-03-3107209577core:SharePremium2024-03-3107209577core:RevaluationReserve2024-03-3107209577core:OtherReservesSubtotal2024-03-3107209577core:RetainedEarningsAccumulatedLosses2024-03-3107209577core:LandBuildings2025-03-3107209577core:PlantMachinery2025-03-3107209577core:Vehicles2025-03-3107209577core:FurnitureFittings2025-03-3107209577core:OfficeEquipment2025-03-3107209577core:NetGoodwill2025-03-3107209577core:IntangibleAssetsOtherThanGoodwill2025-03-3107209577core:ListedExchangeTraded2025-03-3107209577core:UnlistedNon-exchangeTraded2025-03-3107209577core:LandBuildings2024-03-3107209577core:PlantMachinery2024-03-3107209577core:Vehicles2024-03-3107209577core:FurnitureFittings2024-03-3107209577core:OfficeEquipment2024-03-3107209577core:NetGoodwill2024-03-3107209577core:IntangibleAssetsOtherThanGoodwill2024-03-3107209577core:ListedExchangeTraded2024-03-3107209577core:UnlistedNon-exchangeTraded2024-03-3107209577core:LandBuildings2024-04-012025-03-3107209577core:PlantMachinery2024-04-012025-03-3107209577core:Vehicles2024-04-012025-03-3107209577core:FurnitureFittings2024-04-012025-03-3107209577core:OfficeEquipment2024-04-012025-03-3107209577core:NetGoodwill2024-04-012025-03-3107209577core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107209577core:ListedExchangeTraded2024-04-012025-03-3107209577core:UnlistedNon-exchangeTraded2024-04-012025-03-3107209577core:MoreThanFiveYears2024-04-012025-03-3107209577core:Non-currentFinancialInstruments2025-03-3107209577core:Non-currentFinancialInstruments2024-03-3107209577dpl:CostSales2024-04-012025-03-3107209577dpl:DistributionCosts2024-04-012025-03-3107209577core:LandBuildings2024-04-012025-03-3107209577core:PlantMachinery2024-04-012025-03-3107209577core:Vehicles2024-04-012025-03-3107209577core:FurnitureFittings2024-04-012025-03-3107209577core:OfficeEquipment2024-04-012025-03-3107209577dpl:AdministrativeExpenses2024-04-012025-03-3107209577core:NetGoodwill2024-04-012025-03-3107209577core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107209577dpl:GroupUndertakings2024-04-012025-03-3107209577dpl:ParticipatingInterests2024-04-012025-03-3107209577dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3107209577core:ListedExchangeTraded2024-04-012025-03-3107209577dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3107209577core:UnlistedNon-exchangeTraded2024-04-012025-03-3107209577dpl:CostSales2023-04-012024-03-3107209577dpl:DistributionCosts2023-04-012024-03-3107209577core:LandBuildings2023-04-012024-03-3107209577core:PlantMachinery2023-04-012024-03-3107209577core:Vehicles2023-04-012024-03-3107209577core:FurnitureFittings2023-04-012024-03-3107209577core:OfficeEquipment2023-04-012024-03-3107209577dpl:AdministrativeExpenses2023-04-012024-03-3107209577core:NetGoodwill2023-04-012024-03-3107209577core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107209577dpl:GroupUndertakings2023-04-012024-03-3107209577dpl:ParticipatingInterests2023-04-012024-03-3107209577dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3107209577core:ListedExchangeTraded2023-04-012024-03-3107209577dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3107209577core:UnlistedNon-exchangeTraded2023-04-012024-03-3107209577core:NetGoodwill2025-03-3107209577core:IntangibleAssetsOtherThanGoodwill2025-03-3107209577core:LandBuildings2025-03-3107209577core:PlantMachinery2025-03-3107209577core:Vehicles2025-03-3107209577core:FurnitureFittings2025-03-3107209577core:OfficeEquipment2025-03-3107209577core:AfterOneYear2025-03-3107209577core:WithinOneYear2025-03-3107209577core:ListedExchangeTraded2025-03-3107209577core:UnlistedNon-exchangeTraded2025-03-3107209577core:ShareCapital2025-03-3107209577core:SharePremium2025-03-3107209577core:RevaluationReserve2025-03-3107209577core:OtherReservesSubtotal2025-03-3107209577core:RetainedEarningsAccumulatedLosses2025-03-3107209577core:NetGoodwill2024-03-3107209577core:IntangibleAssetsOtherThanGoodwill2024-03-3107209577core:LandBuildings2024-03-3107209577core:PlantMachinery2024-03-3107209577core:Vehicles2024-03-3107209577core:FurnitureFittings2024-03-3107209577core:OfficeEquipment2024-03-3107209577core:AfterOneYear2024-03-3107209577core:WithinOneYear2024-03-3107209577core:ListedExchangeTraded2024-03-3107209577core:UnlistedNon-exchangeTraded2024-03-3107209577core:ShareCapital2024-03-3107209577core:SharePremium2024-03-3107209577core:RevaluationReserve2024-03-3107209577core:OtherReservesSubtotal2024-03-3107209577core:RetainedEarningsAccumulatedLosses2024-03-3107209577core:NetGoodwill2023-03-3107209577core:IntangibleAssetsOtherThanGoodwill2023-03-3107209577core:LandBuildings2023-03-3107209577core:PlantMachinery2023-03-3107209577core:Vehicles2023-03-3107209577core:FurnitureFittings2023-03-3107209577core:OfficeEquipment2023-03-3107209577core:AfterOneYear2023-03-3107209577core:WithinOneYear2023-03-3107209577core:ListedExchangeTraded2023-03-3107209577core:UnlistedNon-exchangeTraded2023-03-3107209577core:ShareCapital2023-03-3107209577core:SharePremium2023-03-3107209577core:RevaluationReserve2023-03-3107209577core:OtherReservesSubtotal2023-03-3107209577core:RetainedEarningsAccumulatedLosses2023-03-3107209577core:AfterOneYear2024-04-012025-03-3107209577core:WithinOneYear2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107209577core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3107209577core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3107209577core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3107209577core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3107209577core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3107209577core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3107209577core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3107209577core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3107209577core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3107209577core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3107209577core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3107209577core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3107209577core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3107209577core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3107209577core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3107209577core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3107209577core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3107209577core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3107209577bus:Director12024-04-012025-03-3107209577bus:Director22024-04-012025-03-3107209577core:FurnitureFittingsToolsEquipment2024-03-3107209577core:FurnitureFittingsToolsEquipment2024-04-012025-03-3107209577core:FurnitureFittingsToolsEquipment2025-03-31

DR. LEATHER LIMITED

Registered Number
07209577
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

DR. LEATHER LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

CASSINGHAM, Darryl Miles
CASSINGHAM, Maria

Registered Address

Ruskin House
Church Road
Bradford Abbas
DT9 6RF

Registered Number

07209577 (England and Wales)
DR. LEATHER LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets324,66532,219
24,66532,219
Current assets
Stocks41,5002,750
Debtors5170,217131,092
Cash at bank and on hand2,677769
174,394134,611
Creditors amounts falling due within one year6(222,735)(159,596)
Net current assets (liabilities)(48,341)(24,985)
Total assets less current liabilities(23,676)7,234
Provisions for liabilities7(3,948)(5,155)
Net assets(27,624)2,079
Capital and reserves
Called up share capital100100
Profit and loss account(27,724)1,979
Shareholders' funds(27,624)2,079
The financial statements were approved and authorised for issue by the Board of Directors on 9 December 2025, and are signed on its behalf by:
CASSINGHAM, Darryl Miles
Director
Registered Company No. 07209577
DR. LEATHER LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Land and buildings-10
Plant and machinery25-
Fixtures and fittings20-
Vehicles25-
Office Equipment25-
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Fixtures & fittings

Total

£££££
Cost or valuation
At 01 April 2412,96141,52322,2015,47582,160
Additions-476--476
At 31 March 2512,96141,99922,2015,47582,636
Depreciation and impairment
At 01 April 247,77722,19317,3712,60049,941
Charge for year1,2964,9521,2075758,030
At 31 March 259,07327,14518,5783,17557,971
Net book value
At 31 March 253,88814,8543,6232,30024,665
At 31 March 245,18419,3304,8302,87532,219
4.Stocks

2025

2024

££
Work in progress-500
Finished goods1,5002,250
Total1,5002,750
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables159,817127,344
Other debtors10,4003,748
Total170,217131,092
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables4,11522,408
Bank borrowings and overdrafts1818
Amounts owed to related parties216,54872,724
Taxation and social security16662,632
Accrued liabilities and deferred income1,8881,814
Total222,735159,596
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)3,9485,155
Total3,9485,155